{ "instance": { "sem-9301810q.htm": { "axisCustom": 1, "axisStandard": 21, "contextCount": 335, "dts": { "calculationLink": { "local": [ "sem-20180930_cal.xml" ] }, "definitionLink": { "local": [ "sem-20180930_def.xml" ] }, "inline": { "local": [ "sem-9301810q.htm" ] }, "labelLink": { "local": [ "sem-20180930_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-doc-2017-01-31.xml", "http://xbrl.sec.gov/dei/2014/dei-doc-2014-01-31.xml" ] }, "presentationLink": { "local": [ "sem-20180930_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-ref-2017-01-31.xml", "http://xbrl.sec.gov/dei/2014/dei-ref-2014-01-31.xml" ] }, "schema": { "local": [ "sem-20180930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2017/elts/us-parts-codification-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2017/elts/us-roles-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2017/elts/us-types-2017-01-31.xsd", "http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd", "http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd", "http://xbrl.sec.gov/exch/2017/exch-2017-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" ] } }, "elementCount": 414, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2017-01-31": 15, "http://xbrl.sec.gov/dei/2014-01-31": 8, "total": 23 }, "keyCustom": 30, "keyStandard": 210, "memberCustom": 31, "memberStandard": 33, "nsprefix": "sem", "nsuri": "http://www.selectmedical.com/20180930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Document and Entity Information", "role": "http://www.selectmedical.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104100 - Disclosure - Intangible Assets", "role": "http://www.selectmedical.com/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105100 - Disclosure - Long-Term Debt and Notes Payable", "role": "http://www.selectmedical.com/role/LongTermDebtAndNotesPayable", "shortName": "Long-Term Debt and Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2106100 - Disclosure - Segment Information", "role": "http://www.selectmedical.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107100 - Disclosure - Revenue from Contracts with Customers", "role": "http://www.selectmedical.com/role/RevenueFromContractsWithCustomers", "shortName": "Revenue from Contracts with Customers", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - Income Taxes", "role": "http://www.selectmedical.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109100 - Disclosure - Income per Common Share", "role": "http://www.selectmedical.com/role/IncomePerCommonShare", "shortName": "Income per Common Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2110100 - Disclosure - Commitments and Contingencies", "role": "http://www.selectmedical.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111100 - Disclosure - Subsequent Events", "role": "http://www.selectmedical.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CondensedFinancialStatementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112100 - Disclosure - Condensed Consolidating Financial Information", "role": "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformation", "shortName": "Condensed Consolidating Financial Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CondensedFinancialStatementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - Accounting Policies (Policies)", "role": "http://www.selectmedical.com/role/AccountingPoliciesPolicies", "shortName": "Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2018Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - Condensed Consolidated Balance Sheets (unaudited)", "role": "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "shortName": "Condensed Consolidated Balance Sheets (unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2018Q3", "decimals": null, "lang": null, "name": "us-gaap:CommitmentsAndContingencies", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "true" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2302302 - Disclosure - Accounting Policies (Tables)", "role": "http://www.selectmedical.com/role/AccountingPoliciesTables", "shortName": "Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - Acquisitions (Tables)", "role": "http://www.selectmedical.com/role/AcquisitionsTables", "shortName": "Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - Intangible Assets (Tables)", "role": "http://www.selectmedical.com/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Long-Term Debt and Notes Payable (Tables)", "role": "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableTables", "shortName": "Long-Term Debt and Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306301 - Disclosure - Segment Information (Tables)", "role": "http://www.selectmedical.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2307301 - Disclosure - Revenue from Contracts with Customers (Tables)", "role": "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersTables", "shortName": "Revenue from Contracts with Customers (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - Income Taxes (Tables)", "role": "http://www.selectmedical.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309301 - Disclosure - Income per Common Share (Tables)", "role": "http://www.selectmedical.com/role/IncomePerCommonShareTables", "shortName": "Income per Common Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD_us-gaap_ConsolidatedEntitiesAxis_us-gaap_SubsidiariesMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCondensedBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312301 - Disclosure - Condensed Consolidating Financial Information (Tables)", "role": "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationTables", "shortName": "Condensed Consolidating Financial Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD_us-gaap_ConsolidatedEntitiesAxis_us-gaap_SubsidiariesMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCondensedBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2018Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402403 - Disclosure - Accounting Policies (Details)", "role": "http://www.selectmedical.com/role/AccountingPoliciesDetails", "shortName": "Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FI2017Q4", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1001501 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)", "role": "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2018Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403402 - Disclosure - Acquisitions - U.S. HealthWorks Acquisition (Details)", "role": "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "shortName": "Acquisitions - U.S. HealthWorks Acquisition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "D2018Q1FEB01_us-gaap_BusinessAcquisitionAxis_sem_U.S.HealthWorksMember", "decimals": "-5", "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3QTD_us-gaap_StatementScenarioAxis_us-gaap_ProFormaMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403403 - Disclosure - Acquisitions - Pro Forma Results (Details)", "role": "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails", "shortName": "Acquisitions - Pro Forma Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3QTD_us-gaap_StatementScenarioAxis_us-gaap_ProFormaMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FI2017Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404402 - Disclosure - Intangible Assets - Carrying Amount of Goodwill (Details)", "role": "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails", "shortName": "Intangible Assets - Carrying Amount of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": "-3", "lang": null, "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2018Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404403 - Disclosure - Intangible Assets - Carrying Value and Amortization of Identifiable Intangible Assets and Liabilities (Details)", "role": "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails", "shortName": "Intangible Assets - Carrying Value and Amortization of Identifiable Intangible Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2017Q4", "decimals": "-3", "lang": null, "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2018Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - Long-Term Debt and Notes Payable - Components of Long-Term Debt And Notes Payable (Details)", "role": "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "shortName": "Long-Term Debt and Notes Payable - Components of Long-Term Debt And Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2018Q3", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2018Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405403 - Disclosure - Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details)", "role": "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "shortName": "Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2018Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "I2017Q1Mar06_us-gaap_ConsolidatedEntitiesAxis_sem_SelectExcludingConcentraMember_us-gaap_DebtInstrumentAxis_sem_A2017SelectCreditFacilitiesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405404 - Disclosure - Long-Term Debt and Notes Payable - Select Credit Facilities (Details)", "role": "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "shortName": "Long-Term Debt and Notes Payable - Select Credit Facilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "I2017Q1Mar06_us-gaap_ConsolidatedEntitiesAxis_sem_SelectExcludingConcentraMember_us-gaap_DebtInstrumentAxis_sem_A2017SelectCreditFacilitiesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "D2018Q1FEB01_us-gaap_ConsolidatedEntitiesAxis_sem_ConcentraIncMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember", "decimals": "INF", "first": true, "lang": null, "name": "sem:LineOfCreditFacilityAdditionalBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405405 - Disclosure - Long-Term Debt and Notes Payable - Concentra Credit Facilities (Details)", "role": "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "shortName": "Long-Term Debt and Notes Payable - Concentra Credit Facilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "D2018Q1FEB01_us-gaap_ConsolidatedEntitiesAxis_sem_ConcentraIncMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember", "decimals": "INF", "first": true, "lang": null, "name": "sem:LineOfCreditFacilityAdditionalBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405406 - Disclosure - Long-Term Debt and Notes Payable - Loss on Early Retirement of Debt (Details)", "role": "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails", "shortName": "Long-Term Debt and Notes Payable - Loss on Early Retirement of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember", "decimals": "-5", "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2018Q3_us-gaap_ConsolidatedEntitiesAxis_sem_SelectExcludingConcentraMember_us-gaap_DebtInstrumentAxis_sem_A6.375SeniorNotesDueJune2021Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405407 - Disclosure - Long-Term Debt and Notes Payable - Fair Value (Details)", "role": "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "shortName": "Long-Term Debt and Notes Payable - Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2018Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002000 - Statement - Condensed Consolidated Statements of Operations (unaudited)", "role": "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "shortName": "Condensed Consolidated Statements of Operations (unaudited)", "subGroupType": "", "uniqueAnchor": null }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2018Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Segment Information - Selected Financial Data (Details)", "role": "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails", "shortName": "Segment Information - Selected Financial Data (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_sem_CriticalIllnessRecoveryHospitalsMember", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "sem:AdjustedEbitda", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406403 - Disclosure - Segment Information - Reconciliation of Adjusted EBITDA to Income Before Taxes (Details)", "role": "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "shortName": "Segment Information - Reconciliation of Adjusted EBITDA to Income Before Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_sem_CriticalIllnessRecoveryHospitalsMember", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3QTD_us-gaap_StatementBusinessSegmentsAxis_sem_CriticalIllnessRecoveryHospitalsMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407402 - Disclosure - Revenue from Contracts with Customers (Details)", "role": "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails", "shortName": "Revenue from Contracts with Customers (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3QTD_us-gaap_StatementBusinessSegmentsAxis_sem_CriticalIllnessRecoveryHospitalsMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3QTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - Income Taxes (Details)", "role": "http://www.selectmedical.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3QTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "FD2018Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409402 - Disclosure - Income per Common Share (Details)", "role": "http://www.selectmedical.com/role/IncomePerCommonShareDetails", "shortName": "Income per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "FD2018Q3QTD", "decimals": "-3", "lang": null, "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "D2015Q4Oct19-Oct19_dei_LegalEntityAxis_sem_SelectSpecialtyHospitalEvansvilleMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_sem_AmendedComplaintMember", "decimals": "INF", "first": true, "lang": null, "name": "sem:NumberOfCaseManagersIdentifiedAsPlaintiff", "reportCount": 1, "unique": true, "unitRef": "hospital", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410401 - Disclosure - Commitments and Contingencies - Litigation (Details)", "role": "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails", "shortName": "Commitments and Contingencies - Litigation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "D2015Q4Oct19-Oct19_dei_LegalEntityAxis_sem_SelectSpecialtyHospitalEvansvilleMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_sem_AmendedComplaintMember", "decimals": "INF", "first": true, "lang": null, "name": "sem:NumberOfCaseManagersIdentifiedAsPlaintiff", "reportCount": 1, "unique": true, "unitRef": "hospital", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "D2018Q1MAR22-MAR22_us-gaap_ConsolidatedEntitiesAxis_sem_SelectExcludingConcentraMember_us-gaap_CreditFacilityAxis_sem_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_sem_A2017SelectCreditFacilitiesAmendmentMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_RangeAxis_us-gaap_MinimumMember_us-gaap_VariableRateAxis_sem_DebtInstrumentVariableRateBaseAdjustedLIBOMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411401 - Disclosure - Subsequent Events - Amendment to the Select Credit Facilities (Details)", "role": "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails", "shortName": "Subsequent Events - Amendment to the Select Credit Facilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "D2018Q4Oct26_us-gaap_ConsolidatedEntitiesAxis_sem_SelectExcludingConcentraMember_us-gaap_CreditFacilityAxis_sem_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_sem_Amendment2SelectCreditFacilitiesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_RangeAxis_us-gaap_MinimumMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_sem_DebtInstrumentVariableRateBaseAdjustedLIBOMember", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "D2018Q1FEB01_us-gaap_ConsolidatedEntitiesAxis_sem_ConcentraIncMember_us-gaap_CreditFacilityAxis_sem_TermLoanFacilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_sem_DebtInstrumentVariableRateBaseAdjustedLIBOMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411402 - Disclosure - Subsequent Events - Amendment to the Concentra Credit Facilities (Details)", "role": "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "shortName": "Subsequent Events - Amendment to the Concentra Credit Facilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "body", "html" ], "contextRef": "D2018Q4Oct26_us-gaap_ConsolidatedEntitiesAxis_sem_ConcentraIncMember_us-gaap_CreditFacilityAxis_sem_TermLoanFacilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_sem_DebtInstrumentVariableRateBaseAdjustedLIBOMember", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2018Q3_us-gaap_ConsolidatedEntitiesAxis_us-gaap_SubsidiariesMember_us-gaap_DebtInstrumentAxis_us-gaap_SeniorNotesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412402 - Disclosure - Condensed Consolidating Financial Information - Narrative (Details)", "role": "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationNarrativeDetails", "shortName": "Condensed Consolidating Financial Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2018Q3_us-gaap_ConsolidatedEntitiesAxis_us-gaap_SubsidiariesMember_us-gaap_DebtInstrumentAxis_us-gaap_SeniorNotesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2018Q3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412403 - Disclosure - Condensed Consolidating Financial Information - Condensed Consolidating Balance Sheet (Details)", "role": "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "shortName": "Condensed Consolidating Financial Information - Condensed Consolidating Balance Sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FI2018Q3_us-gaap_ConsolidationItemsAxis_us-gaap_ConsolidationEliminationsMember", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2017Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - Condensed Consolidated Statements of Changes in Equity and Income (unaudited)", "role": "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited", "shortName": "Condensed Consolidated Statements of Changes in Equity and Income (unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": "-3", "lang": null, "name": "us-gaap:TemporaryEquityNetIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2018Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412404 - Disclosure - Condensed Consolidating Financial Information - Condensed Consolidating Statement of Operations (Details)", "role": "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "shortName": "Condensed Consolidating Financial Information - Condensed Consolidating Statement of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3QTD_us-gaap_ConsolidationItemsAxis_us-gaap_ConsolidationEliminationsMember", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2018Q3QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412405 - Disclosure - Condensed Consolidating Financial Information - Condensed Consolidating Statement of Cash Flows (Details)", "role": "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "shortName": "Condensed Consolidating Financial Information - Condensed Consolidating Statement of Cash Flows (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q3YTD_us-gaap_ConsolidationItemsAxis_us-gaap_ConsolidationEliminationsMember", "decimals": "-3", "lang": null, "name": "us-gaap:EquityMethodInvestmentDividendsOrDistributions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)", "role": "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": "-3", "lang": null, "name": "us-gaap:PaymentsForRepurchaseOfEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - Basis of Presentation", "role": "http://www.selectmedical.com/role/BasisOfPresentation", "shortName": "Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102100 - Disclosure - Accounting Policies", "role": "http://www.selectmedical.com/role/AccountingPolicies", "shortName": "Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103100 - Disclosure - Acquisitions", "role": "http://www.selectmedical.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2018Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 66, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "If the value is true, then the document is an amendment to previously-filed/accepted document.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word \"Other\".", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r273" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "domainItemType" }, "dei_EntityFilerCategory": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r273" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "stringItemType" }, "sem_A2017SelectCreditFacilitiesAmendmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2017 Select Credit Facilities Amendment [Member]", "label": "2017 Select Credit Facilities Amendment [Member]", "terseLabel": "2017 Select Credit Facilities Amendment" } } }, "localname": "A2017SelectCreditFacilitiesAmendmentMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_A2017SelectCreditFacilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2017 Select Credit Facilities [Member]", "label": "2017 Select Credit Facilities [Member]", "terseLabel": "2017 Select Credit Facilities" } } }, "localname": "A2017SelectCreditFacilitiesMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_A6.375SeniorNotesDueJune2021Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "6.375% Senior Notes Due June 2021 [Member]", "label": "6.375% Senior Notes Due June 2021 [Member]", "terseLabel": "6.375% Senior Notes Due June 2021" } } }, "localname": "A6.375SeniorNotesDueJune2021Member", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "sem_AccreditationsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the information pertaining to accreditations.", "label": "Accreditations [Member]", "terseLabel": "Accreditations" } } }, "localname": "AccreditationsMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_AdditionalInvestmentByHoldings": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Additional Investment by Holdings (Parent).", "label": "Additional Investment by Holdings", "terseLabel": "Additional investment by Holdings" } } }, "localname": "AdditionalInvestmentByHoldings", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "sem_AdjustedEbitda": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, acquisition costs associated with US Healthworks, non-operating gain (loss), and equity in earnings (losses) of unconsolidated subsidiaries.", "label": "Adjusted EBITDA", "terseLabel": "Adjusted EBITDA" } } }, "localname": "AdjustedEbitda", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "monetaryItemType" }, "sem_AmendedComplaintMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the amended complaint in United States of America and the State of Indiana unsealed by a federal magistrate judge.", "label": "Amended Complaint [Member]", "terseLabel": "Amended complaint" } } }, "localname": "AmendedComplaintMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "domainItemType" }, "sem_Amendment2SelectCreditFacilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Amendment 2, Select Credit Facilities [Member]", "label": "Amendment 2, Select Credit Facilities [Member]", "terseLabel": "Amendment No. 2, Select Credit Facilities" } } }, "localname": "Amendment2SelectCreditFacilitiesMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_BusinessAcquisitionEquityInterestIssuedorIssuablePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Percentage", "label": "Business Acquisition, Equity Interest Issued or Issuable, Percentage", "terseLabel": "Equity interest issued (percent)" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedorIssuablePercentage", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "percentItemType" }, "sem_BusinessAcquisitionProFormaNetIncomeLossAttributableToParent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Business Acquisition, Pro Forma Net Income (Loss) Attributable To Parent", "label": "Business Acquisition, Pro Forma Net Income (Loss) Attributable To Parent", "terseLabel": "Net income attributable to the Company" } } }, "localname": "BusinessAcquisitionProFormaNetIncomeLossAttributableToParent", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails" ], "xbrltype": "monetaryItemType" }, "sem_BusinessAcquisitionProformaAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents acquisition costs excluded from proforma results.", "label": "Business Acquisition Proforma [Abstract]", "terseLabel": "Acquisition costs" } } }, "localname": "BusinessAcquisitionProformaAbstract", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails" ], "xbrltype": "stringItemType" }, "sem_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tangible Assets", "terseLabel": "Identifiable tangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "sem_CertificatesOfNeedMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the information pertaining to certificates of need, a legal document of the entity.", "label": "Certificates Of Need [Member]", "terseLabel": "Certificates of need" } } }, "localname": "CertificatesOfNeedMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_ChangeInIntercompanyAccount": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the change in amounts owed to or receivable from other subsidiaries.", "label": "Change In Intercompany Account", "negatedTerseLabel": "Intercompany" } } }, "localname": "ChangeInIntercompanyAccount", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "sem_ConcentraGroupHoldingsParentLlcMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the entity Concentra Group Holdings Parent, LLC (\"Group Holdings Parent\").", "label": "Concentra Group Holdings Parent Llc [Member]", "terseLabel": "Concentra Group Holdings Parent, LLC" } } }, "localname": "ConcentraGroupHoldingsParentLlcMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "domainItemType" }, "sem_ConcentraIncMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the information about Concentra Inc, a subsidiary of Humana.", "label": "Concentra Inc [Member]", "terseLabel": "Concentra Inc" } } }, "localname": "ConcentraIncMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_ConcentraMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the information pertaining to Concentra, a reporting segment of the entity.", "label": "Concentra [Member]", "terseLabel": "Concentra" } } }, "localname": "ConcentraMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails", "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "domainItemType" }, "sem_ContributionRelatedToRestrictedStockAwardsAndStockOptionIssuancesByHoldings": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Contribution related to restricted stock award issuances by Holdings (Parent).", "label": "Contribution Related to Restricted Stock Awards and Stock Option Issuances by Holdings", "terseLabel": "Contribution related to restricted stock award issuances by Holdings" } } }, "localname": "ContributionRelatedToRestrictedStockAwardsAndStockOptionIssuancesByHoldings", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "sem_CorporateReconcilingItemsAndEliminationsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Corporate services and certain other non-consolidating joint ventures and minority investments in other businesses that are not considered operating segments. Also includes eliminating entries used in consolidating a parent entity and its subsidiaries, and items used in reconciling reportable segments' amounts to consolidated amount.", "label": "Corporate Reconciling Items And Eliminations [Member]", "terseLabel": "Other" } } }, "localname": "CorporateReconcilingItemsAndEliminationsMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "domainItemType" }, "sem_CriticalIllnessRecoveryHospitalsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Critical Illness Recovery Hospitals [Member]", "label": "Critical Illness Recovery Hospitals [Member]", "terseLabel": "Critical Illness Recovery Hospital" } } }, "localname": "CriticalIllnessRecoveryHospitalsMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails", "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "domainItemType" }, "sem_CustomerRelationshipNoncompeteAgreementsAndTrademarksMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Customer Relationship, Noncompete Agreements, And Trademarks [Member]", "label": "Customer Relationship, Noncompete Agreements, And Trademarks [Member]", "terseLabel": "Customer relationships, non-compete agreements, and trademarks" } } }, "localname": "CustomerRelationshipNoncompeteAgreementsAndTrademarksMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_DebtInstrumentAlternateBaseRateFloorMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the alternate base rate floor used to calculate the variable interest rate of the debt instrument.", "label": "Debt Instrument Alternate Base Rate Floor [Member]", "terseLabel": "Alternate Base Rate floor" } } }, "localname": "DebtInstrumentAlternateBaseRateFloorMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_DebtInstrumentCollateralPercentageOfNonVotingCapitalStockOfForeignSubsidiaries": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Collateral, Percentage Of Non-Voting Capital Stock Of Foreign Subsidiaries", "label": "Debt Instrument, Collateral, Percentage Of Non-Voting Capital Stock Of Foreign Subsidiaries", "terseLabel": "Non-voting capital stock of foreign subsidiaries pledged (as a percent)" } } }, "localname": "DebtInstrumentCollateralPercentageOfNonVotingCapitalStockOfForeignSubsidiaries", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "sem_DebtInstrumentCollateralPercentageOfVotingCapitalStockOfDomesticSubsidiaries": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Collateral, Percentage Of Voting Capital Stock Of Domestic Subsidiaries", "label": "Debt Instrument, Collateral, Percentage Of Voting Capital Stock Of Domestic Subsidiaries", "terseLabel": "Voting capital stock of domestic subsidiaries pledged (as a percent)" } } }, "localname": "DebtInstrumentCollateralPercentageOfVotingCapitalStockOfDomesticSubsidiaries", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "sem_DebtInstrumentCovenantLeverageRatio": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the leverage ratio as defined in the credit facility agreement", "label": "Debt Instrument Covenant, Leverage Ratio", "terseLabel": "Leverage ratio of financial maintenance covenant" } } }, "localname": "DebtInstrumentCovenantLeverageRatio", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "pureItemType" }, "sem_DebtInstrumentCovenantPrepaymentPremiumRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the premium for term loans prepayments.", "label": "Debt Instrument Covenant, Prepayment Premium Rate", "terseLabel": "Prepayment premium rate" } } }, "localname": "DebtInstrumentCovenantPrepaymentPremiumRate", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "sem_DebtInstrumentFinancialCovenantsRatiosAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lists down various ratios required to be maintained under the financial covenants pertaining to debt instrument.", "label": "Debt Instrument Financial Covenants Ratios [Axis]", "terseLabel": "Debt Instrument Financial Covenants Ratios [Axis]" } } }, "localname": "DebtInstrumentFinancialCovenantsRatiosAxis", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "sem_DebtInstrumentFinancialCovenantsRatiosDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categorization of various ratios required to be maintained under the financial covenants pertaining to debt instrument.", "label": "Debt Instrument Financial Covenants Ratios [Domain]", "terseLabel": "Debt Instrument Financial Covenants Ratios [Domain]" } } }, "localname": "DebtInstrumentFinancialCovenantsRatiosDomain", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_DebtInstrumentPercentageofNetProceedsfromAssetorOtherDispositionorCasualtyorCondemnationtobeUsedforPrepayment": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the percentage of net cash proceeds from all sales of assets or other dispositions by the entity or as a result of casualty or condemnation, subject to reinvestment provisions and other customary adjustments, required to be used for the prepayment of the debt instrument.", "label": "Debt Instrument, Percentage of Net Proceeds from Asset or Other Disposition or Casualty or Condemnation to be Used for Prepayment", "terseLabel": "Percentage of net cash proceeds received from non-ordinary course asset sales or other dispositions, or as a result of a casualty or condemnation to be used for prepayment of debt" } } }, "localname": "DebtInstrumentPercentageofNetProceedsfromAssetorOtherDispositionorCasualtyorCondemnationtobeUsedforPrepayment", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "sem_DebtInstrumentPrepaymentasPercentageofExcessCashFlows": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the mandatory prepayment as a percentage of excess cash flows for any fiscal year if a specified leverage ratio is outside the threshold specified in the agreement.", "label": "Debt Instrument, Prepayment as Percentage of Excess Cash Flows", "terseLabel": "Percentage of excess cash flow to be used for prepayment of debt" } } }, "localname": "DebtInstrumentPrepaymentasPercentageofExcessCashFlows", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "sem_DebtInstrumentPrepaymentasPercentageofProceedsofSpecifiedDebtIssuance": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the mandatory prepayment as a percentage of the proceeds received from specified debt issuance.", "label": "Debt Instrument, Prepayment as Percentage of Proceeds of Specified Debt Issuance", "terseLabel": "Percentage of net proceeds received from the issuance of debt obligations other than certain permitted debt obligations to be used for prepayment of debt" } } }, "localname": "DebtInstrumentPrepaymentasPercentageofProceedsofSpecifiedDebtIssuance", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "sem_DebtInstrumentVariableRateBaseAdjustedLIBOFloorMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The adjusted London Interbank Offered floor rate (LIBO) used to calculate the variable interest rate of the debt instrument.", "label": "Debt Instrument Variable Rate Base Adjusted LIBO Floor [Member]", "terseLabel": "Adjusted LIBO Rate floor" } } }, "localname": "DebtInstrumentVariableRateBaseAdjustedLIBOFloorMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_DebtInstrumentVariableRateBaseAdjustedLIBOMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The adjusted London Interbank Offered rate (LIBO) used to calculate the variable interest rate of the debt instrument.", "label": "Debt Instrument Variable Rate Base Adjusted LIBO [Member]", "terseLabel": "Adjusted LIBO" } } }, "localname": "DebtInstrumentVariableRateBaseAdjustedLIBOMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_DividendsDeclaredAndPaidToHoldings": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared to Select Medical Holdings Corporation, with the form of settlement in cash.", "label": "Dividends Declared and Paid to Holdings", "negatedLabel": "Dividends declared and paid to Holdings" } } }, "localname": "DividendsDeclaredAndPaidToHoldings", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "sem_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "", "label": "Document and Entity Information" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.selectmedical.com/20180930", "xbrltype": "stringItemType" }, "sem_ExchangeOfEquityInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Exchange Of Equity Interest", "label": "Exchange Of Equity Interest", "terseLabel": "Issuance and exchange of non-controlling interests" } } }, "localname": "ExchangeOfEquityInterest", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of finite-lived and indefinite-lived intangible assets and liabilities, excluding goodwill, in total and by major class.", "label": "Finite Lived And Indefinite Lived Intangible Assets And Liabilities By Major Class [Table]", "terseLabel": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]" } } }, "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]", "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]", "terseLabel": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]" } } }, "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "sem_GainLossOnSaleDispositionOfAssetsAndBusiness": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Gain (loss) from sale or disposal of assets and an organization or integrated set of activities (for example, but not limited to, a partnership or corporation) engaged in providing a product or service in a commercial, industrial, or professional environment.", "label": "Gain (Loss) on Sale or Disposition of Assets and Business", "negatedLabel": "Gain on sale of assets and businesses", "negatedTerseLabel": "Loss (gain) on sale of assets and businesses" } } }, "localname": "GainLossOnSaleDispositionOfAssetsAndBusiness", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "sem_GainLossonExtinguishmentofDebtDebtModification": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails": { "order": 2.0, "parentTag": "us-gaap_GainsLossesOnExtinguishmentOfDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Gain (Loss) on Extinguishment of Debt, Debt Modification", "label": "Gain (Loss) on Extinguishment of Debt, Debt Modification", "negatedLabel": "Loss on early retirement of debt, debt modification losses" } } }, "localname": "GainLossonExtinguishmentofDebtDebtModification", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "sem_HealthCarePatientServiceMedicareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care, Patient Service - Medicare [Member]", "label": "Health Care, Patient Service - Medicare [Member]", "terseLabel": "Medicare" } } }, "localname": "HealthCarePatientServiceMedicareMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails" ], "xbrltype": "domainItemType" }, "sem_HealthCarePatientServiceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care, Patient Service [Member]", "label": "Health Care, Patient Service [Member]", "terseLabel": "Patient services revenue" } } }, "localname": "HealthCarePatientServiceMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails" ], "xbrltype": "domainItemType" }, "sem_HealthCarePatientServiceNonMedicareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care, Patient Service - Non-Medicare [Member]", "label": "Health Care, Patient Service - Non-Medicare [Member]", "terseLabel": "Non-Medicare" } } }, "localname": "HealthCarePatientServiceNonMedicareMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails" ], "xbrltype": "domainItemType" }, "sem_IncomeLossFromSubsidiaries": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This item represents the entity's proportionate share for the period of the income (loss) of its consolidated subsidiary.", "label": "Income (Loss) from Subsidiaries", "negatedLabel": "Equity in earnings of consolidated subsidiaries", "terseLabel": "Equity in earnings of consolidated subsidiaries" } } }, "localname": "IncomeLossFromSubsidiaries", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "sem_IndefiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the weighted average period before the next renewal or extension (both explicit and implicit) for indefinite-lived intangible assets that have been renewed or extended.", "label": "Indefinite Lived Intangible Asset Weighted Average Period before Next Renewal or Extension", "terseLabel": "Weighted average time until next renewal" } } }, "localname": "IndefiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "sem_IntercompanyInterestAndRoyaltyFees": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the amount of intercompany interest and royalty fees.", "label": "Intercompany Interest and Royalty Fees", "negatedLabel": "Intercompany interest and royalty fees" } } }, "localname": "IntercompanyInterestAndRoyaltyFees", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "sem_IntercompanyPayables": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents information pertaining to the amounts owed to other subsidiaries.", "label": "Intercompany Payables", "terseLabel": "Intercompany payables" } } }, "localname": "IntercompanyPayables", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "sem_IntercompanyReceivables": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents information pertaining to the amounts due from other subsidiaries.", "label": "Intercompany Receivables", "terseLabel": "Intercompany receivables" } } }, "localname": "IntercompanyReceivables", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "sem_InvestedEquityinSubsidiary": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the Parent's equity investment in its subsidiaries.", "label": "Invested Equity in Subsidiary", "terseLabel": "Subsidiary investment" } } }, "localname": "InvestedEquityinSubsidiary", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "sem_LessThanOrEqualTo4.25To1.00AndGreaterThan3.75To1.00Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Less Than Or Equal To 4.25 To 1.00 And Greater Than 3.75 To 1.00 [Member]", "label": "Less Than Or Equal To 4.25 To 1.00 And Greater Than 3.75 To 1.00 [Member]", "terseLabel": "Less than or equal to 4.25 to 1.00 and greater than 3.75 to 1.00" } } }, "localname": "LessThanOrEqualTo4.25To1.00AndGreaterThan3.75To1.00Member", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_LeverageRatioGreaterThan4.25To1.00Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Leverage Ratio Greater Than 4.25 To 1.00 [Member]", "label": "Leverage Ratio Greater Than 4.25 To 1.00 [Member]", "terseLabel": "Leverage ratio greater than 4.25 to 1.00" } } }, "localname": "LeverageRatioGreaterThan4.25To1.00Member", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_LeverageRatioLessThanOrEqualTo3.75To1.00Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Leverage Ratio Less Than Or Equal To 3.75 To 1.00", "label": "Leverage Ratio Less Than Or Equal To 3.75 To 1.00 [Member]", "terseLabel": "Leverage ratio less than or equal to 3.75 to 1.00" } } }, "localname": "LeverageRatioLessThanOrEqualTo3.75To1.00Member", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_LineOfCreditFacilityAdditionalBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line Of Credit Facility, Additional Borrowing Capacity", "label": "Line Of Credit Facility, Additional Borrowing Capacity", "terseLabel": "Additional borrowing capacity" } } }, "localname": "LineOfCreditFacilityAdditionalBorrowingCapacity", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "sem_NonGuarantorConcentraMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Entity owned or controlled by entity which has not guaranteed the issue of securities by another subsidiary of the parent or has not guaranteed the issue of securities by the parent.", "label": "Non Guarantor Concentra [Member]", "terseLabel": "Non-Guarantor Concentra" } } }, "localname": "NonGuarantorConcentraMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "sem_NumberOfCaseManagersIdentifiedAsPlaintiff": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the number of case managers identified as plaintiff under the amended complaint.", "label": "Number of Case Managers Identified as Plaintiff", "terseLabel": "Number of case managers identified as plaintiff" } } }, "localname": "NumberOfCaseManagersIdentifiedAsPlaintiff", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "integerItemType" }, "sem_OutpatientRehabilitationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the information pertaining to outpatient rehabilitation, a reporting segment of the entity.", "label": "Outpatient Rehabilitation [Member]", "terseLabel": "Outpatient Rehabilitation" } } }, "localname": "OutpatientRehabilitationMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails", "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "domainItemType" }, "sem_OutstandingBookOverdrafts": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents outstanding checks in excess of funds on deposit.", "label": "Outstanding Book Overdrafts", "terseLabel": "Overdrafts" } } }, "localname": "OutstandingBookOverdrafts", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "sem_ProceedsFromSaleOfAssetsAndDivestitureOfBusinesses": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate cash proceeds received from a combination of transactions that are classified as investing activities. Includes proceeds from the sale of assets and organizations or integrated set of activities (for example, but not limited to, a partnership or corporation) engaged in providing a product or service in a commercial, industrial, or professional environment, are sold to third-party buyers.", "label": "Proceeds From Sale Of Assets And Divestiture Of Businesses", "terseLabel": "Proceeds from sale of assets and businesses" } } }, "localname": "ProceedsFromSaleOfAssetsAndDivestitureOfBusinesses", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "sem_RehabilitationHospitalsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Rehabilitation Hospitals [Member]", "label": "Rehabilitation Hospitals [Member]", "terseLabel": "Rehabilitation Hospital" } } }, "localname": "RehabilitationHospitalsMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails", "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "domainItemType" }, "sem_SecondLienCreditAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents information pertaining to Second Lien Credit Agreement Member.", "label": "Second Lien Credit Agreement [Member]", "terseLabel": "Concentra second lien term agreement" } } }, "localname": "SecondLienCreditAgreementMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_SelectExcludingConcentraMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents information about Select excluding Concentra Inc.", "label": "Select Excluding Concentra [Member]", "terseLabel": "Select Excluding Concentra" } } }, "localname": "SelectExcludingConcentraMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_SelectSpecialtyHospitalEvansvilleMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents information pertaining to Select Specialty Hospital - Evansville, a long term acute care hospital of the entity, located in Evansville, Indiana.", "label": "Select Specialty Hospital Evansville [Member]", "terseLabel": "SSH-Evansville" } } }, "localname": "SelectSpecialtyHospitalEvansvilleMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "domainItemType" }, "sem_ServiceOtherMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Service, Other [Member]", "label": "Service, Other [Member]", "terseLabel": "Other revenues" } } }, "localname": "ServiceOtherMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails" ], "xbrltype": "domainItemType" }, "sem_TemporaryEquityDistributionsToNonControllingInterests": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Decrease in temporary equity balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Temporary Equity, Distributions To Non-Controlling Interests", "negatedLabel": "Distributions to and purchases of non-controlling interests" } } }, "localname": "TemporaryEquityDistributionsToNonControllingInterests", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "sem_TemporaryEquityExchangeOfEquityInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Temporary Equity, Exchange Of Equity Interest", "label": "Temporary Equity, Exchange Of Equity Interest", "terseLabel": "Issuance and exchange of non-controlling interests" } } }, "localname": "TemporaryEquityExchangeOfEquityInterest", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "sem_TermLoanFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents information pertaining to the term loan facility of the entity.", "label": "Term Loan Facility [Member]", "terseLabel": "Term loans" } } }, "localname": "TermLoanFacilityMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "sem_U.S.HealthWorksMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the information pertaining to U.S. HealthWorks.", "label": "U.S. HealthWorks [Member]", "terseLabel": "U.S. HealthWorks" } } }, "localname": "U.S.HealthWorksMember", "nsuri": "http://www.selectmedical.com/20180930", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails", "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201409Member": { "auth_ref": [ "r178" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).", "label": "Accounting Standards Update 2014-09 [Member]", "terseLabel": "Accounting Standards Update 2014-09" } } }, "localname": "AccountingStandardsUpdate201409Member", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r28" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r17", "r257" ], "calculation": { "http://www.selectmedical.com/role/AccountingPoliciesDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amounts due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.", "label": "Accounts Receivable, Gross, Current", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r17", "r23" ], "calculation": { "http://www.selectmedical.com/role/AccountingPoliciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.", "label": "Accounts Receivable, Net, Current", "totalLabel": "Accounts receivable", "verboseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails", "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedVacationCurrent": { "auth_ref": [ "r7", "r32", "r180" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Vacation, Current", "terseLabel": "Accrued vacation" } } }, "localname": "AccruedVacationCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r130" ], "lang": { "en-US": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted Average Amortization Period" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r18" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Capital in excess of par" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Capital in Excess of Par" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by new accounting pronouncement.", "label": "Adjustments for New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) resulting from recognition of equity-based compensation for restricted stock units.", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Restricted Stock Unit or Restricted Stock Award, Requisite Service Period Recognition", "terseLabel": "Vesting of restricted stock" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "verboseLabel": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r181", "r183", "r185" ], "calculation": { "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.", "label": "Allocated Share-based Compensation Expense", "negatedLabel": "Stock compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r40", "r114" ], "calculation": { "http://www.selectmedical.com/role/AccountingPoliciesDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.", "label": "Allowance for Doubtful Accounts Receivable, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r71" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discount, premium and issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r70", "r128", "r135" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r241", "r258" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r6", "r42" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Alternate Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails", "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r199", "r200" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails", "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "auth_ref": [ "r209" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "terseLabel": "Non-cash equity exchange for acquisition of U.S. HealthWorks" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Acquisitions" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails", "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": { "auth_ref": [ "r198" ], "lang": { "en-US": { "role": { "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic", "terseLabel": "Basic income per common share (in dollars per share)" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": { "auth_ref": [ "r198" ], "lang": { "en-US": { "role": { "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted", "terseLabel": "Diluted income per common share (in dollars per share)" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Acquisition, Pro Forma Information [Abstract]", "verboseLabel": "Pro forma results of operations" } } }, "localname": "BusinessAcquisitionProFormaInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r198" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Schedule of pro forma unaudited results of operations" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": { "auth_ref": [ "r210" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.", "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount", "terseLabel": "Estimated value of goodwill, deductible for tax purposes" } } }, "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r198" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net income" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r198" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Net revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r196" ], "calculation": { "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "negatedLabel": "U.S. HealthWorks acquisition costs", "terseLabel": "U.S. HealthWorks acquisition costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails", "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r206", "r207", "r208" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Total consideration (net of cash acquired)" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r211" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [ "r197" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual", "terseLabel": "Net revenues of acquiree" } } }, "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r201" ], "calculation": { "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r201" ], "calculation": { "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Identifiable intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]", "terseLabel": "Identifiable intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r201" ], "calculation": { "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "verboseLabel": "Total liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r201" ], "calculation": { "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Consideration given" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]", "terseLabel": "Consideration given for the acquired business" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r24", "r72" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [ "r66", "r226" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease)", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r37", "r142", "r246", "r264" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 10)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r141", "r149" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r16", "r164" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r16" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CondensedFinancialStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Financial Statements, Captions [Line Items]", "terseLabel": "Condensed Financial Statements, Captions [Line Items]" } } }, "localname": "CondensedFinancialStatementsCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationTables" ], "xbrltype": "stringItemType" }, "us-gaap_CondensedFinancialStatementsTextBlock": { "auth_ref": [ "r79", "r100", "r216" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for condensed financial statements.", "label": "Condensed Financial Statements [Text Block]", "terseLabel": "Condensed Consolidating Financial Information" } } }, "localname": "CondensedFinancialStatementsTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidatedEntitiesAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationNarrativeDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationTables", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConsolidatedEntitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationNarrativeDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationTables", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationEliminationsMember": { "auth_ref": [ "r222" ], "lang": { "en-US": { "role": { "documentation": "Eliminating entries used in consolidating a parent entity and its subsidiaries.", "label": "Consolidation, Eliminations [Member]", "terseLabel": "Consolidating and Eliminating Adjustments" } } }, "localname": "ConsolidationEliminationsMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationItemsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateJointVentureMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project.", "label": "Corporate Joint Venture [Member]", "terseLabel": "Joint Venture Operations" } } }, "localname": "CorporateJointVentureMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfServices": { "auth_ref": [ "r51" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Total costs related to services rendered by an entity during the reporting period.", "label": "Cost of Services", "terseLabel": "Cost of services" } } }, "localname": "CostOfServices", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r47" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r205" ], "lang": { "en-US": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r158" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Long-Term Debt and Notes Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r12", "r13", "r14", "r242", "r243", "r256" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationNarrativeDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Interest rate margin (as a percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r14", "r243", "r256" ], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 }, "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Principal Outstanding", "totalLabel": "Total" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r228", "r231" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r224", "r225" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair Value" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r34" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate of debt (as a percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationNarrativeDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationNarrativeDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r35" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationNarrativeDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period One [Member]", "terseLabel": "On or prior to February 1, 2019" } } }, "localname": "DebtInstrumentRedemptionPeriodOneMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Two [Member]", "terseLabel": "On or prior to February 1, 2020" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r35", "r75", "r165", "r166", "r167", "r168", "r227", "r228", "r231", "r254" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationNarrativeDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument term (in years)" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r227", "r228", "r229", "r230", "r231" ], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Debt Instrument, Unamortized Discount (Premium), Net", "negatedLabel": "Unamortized Premium (Discount)" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r70", "r74", "r191", "r193" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r186", "r189" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Non-current deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r70", "r139" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "negatedLabel": "Depreciation and amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r176" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of disaggregation of net operating revenues by operating segment" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureTextBlockSupplementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Disclosure Text Block Supplement [Abstract]" } } }, "localname": "DisclosureTextBlockSupplementAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Income per common share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r46", "r91", "r95", "r96", "r250", "r267" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Basic income per common share: (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Income per common share" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r46", "r91", "r250", "r267" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted income per common share: (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r97" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Income per Common Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomePerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r77", "r187", "r188" ], "calculation": { "http://www.selectmedical.com/role/IncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Total effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r187", "r188", "r192" ], "calculation": { "http://www.selectmedical.com/role/IncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Federal income tax at statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r187", "r188", "r192" ], "calculation": { "http://www.selectmedical.com/role/IncomeTaxesDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": { "auth_ref": [ "r187", "r188", "r192" ], "calculation": { "http://www.selectmedical.com/role/IncomeTaxesDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.", "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent", "negatedTerseLabel": "Non-controlling interest" } } }, "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "auth_ref": [ "r187", "r188", "r192" ], "calculation": { "http://www.selectmedical.com/role/IncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent", "terseLabel": "Permanent differences" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r187", "r188", "r192" ], "calculation": { "http://www.selectmedical.com/role/IncomeTaxesDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity-based compensation costs.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Percent", "terseLabel": "Stock-based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r187", "r188", "r192" ], "calculation": { "http://www.selectmedical.com/role/IncomeTaxesDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r187", "r188", "r192" ], "calculation": { "http://www.selectmedical.com/role/IncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State and local income taxes, less federal income tax benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": { "auth_ref": [ "r187", "r188", "r192" ], "calculation": { "http://www.selectmedical.com/role/IncomeTaxesDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.", "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent", "terseLabel": "Uncertain tax positions" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued payroll" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r164" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentDividendsOrDistributions": { "auth_ref": [ "r44", "r65", "r70", "r265" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.", "label": "Proceeds from Equity Method Investment, Distribution", "terseLabel": "Distributions from unconsolidated subsidiaries" } } }, "localname": "EquityMethodInvestmentDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r134" ], "calculation": { "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Finite-lived intangible assets, accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year", "terseLabel": "2018" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "2020" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "2019" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r129", "r133" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]", "terseLabel": "Estimated amortization expense" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r134" ], "calculation": { "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Finite-lived intangible assets, gross carrying amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r129", "r133" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r134" ], "calculation": { "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Finite-lived intangible assets, net carrying amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]", "terseLabel": "Amortized intangible assets:" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r70", "r156", "r157" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTotalLabel": "Loss on early retirement of debt", "terseLabel": "Loss on early retirement of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r52" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r119", "r120", "r121" ], "calculation": { "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "September 30, 2018", "periodStartLabel": "December 31, 2017", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r122" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "verboseLabel": "Acquired" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Carrying amount of goodwill" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r124", "r195" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Measurement period adjustment" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": { "auth_ref": [ "r123" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Written off Related to Sale of Business Unit", "negatedTerseLabel": "Sold" } } }, "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuarantorSubsidiariesMember": { "auth_ref": [ "r154" ], "lang": { "en-US": { "role": { "documentation": "Entity owned or controlled by another entity which has guaranteed the issue of securities by another subsidiary of the parent or has guaranteed the issue of securities by the parent.", "label": "Guarantor Subsidiaries [Member]", "terseLabel": "Subsidiary Guarantors" } } }, "localname": "GuarantorSubsidiariesMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r43", "r240", "r248", "r268" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r44", "r70", "r116", "r247", "r265" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Equity in earnings of unconsolidated subsidiaries", "terseLabel": "Equity in earnings of unconsolidated subsidiaries", "verboseLabel": "Equity in earnings of unconsolidated subsidiaries" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r194" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r78", "r190" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense", "verboseLabel": "Income tax expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r73" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r69" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r69" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable", "negatedTerseLabel": "Changes in accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r69" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInBookOverdrafts": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) in cash during the period due to the net increase or decrease in book overdrafts.", "label": "Increase (Decrease) in Book Overdrafts", "terseLabel": "Decrease in overdrafts" } } }, "localname": "IncreaseDecreaseInBookOverdrafts", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxes": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets.", "label": "Increase (Decrease) in Income Taxes", "terseLabel": "Income taxes" } } }, "localname": "IncreaseDecreaseInIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of effects of business combinations:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r69" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "terseLabel": "Redeemable Non-controlling Interests" } } }, "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r92", "r95" ], "calculation": { "http://www.selectmedical.com/role/IncomePerCommonShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Stock options (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r137" ], "lang": { "en-US": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r137" ], "calculation": { "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Indefinite-lived intangible assets, carrying amount" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r131", "r137" ], "lang": { "en-US": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Total identifiable intangible assets, gross carrying amount" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r127", "r132" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Identifiable intangible assets, net", "totalLabel": "Total identifiable intangible assets, net carrying amount" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r251" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "terseLabel": "Interest expense", "verboseLabel": "Interest income (expense)" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r73" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid, after deduction of cash paid for capitalized interest, for interest. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Net", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r8", "r9", "r32" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r25" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "terseLabel": "Investment in affiliates" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r31" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r22", "r245", "r262" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY", "verboseLabel": "Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r33" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Current Borrowing Capacity", "terseLabel": "Current borrowing capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r29", "r75" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Credit facilities" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r14", "r243", "r259" ], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Carrying Value" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r14" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt and capital lease obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Long-term Debt and Capital Lease Obligations", "terseLabel": "Long-term debt, net of current portion" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt and capital leases due within one year or the normal operating cycle, if longer.", "label": "Long-term Debt and Capital Lease Obligations, Current", "terseLabel": "Current portion of long-term debt and notes payable" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r80", "r152" ], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "order": 6.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r80", "r152" ], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "order": 5.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Year Five", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r80", "r152" ], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "order": 4.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r80", "r152" ], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three", "terseLabel": "2020" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r80", "r152" ], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two", "terseLabel": "2019" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r80" ], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year", "terseLabel": "2018" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r35" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r35", "r153" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r150", "r151" ], "lang": { "en-US": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r150", "r151" ], "lang": { "en-US": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r150", "r151" ], "lang": { "en-US": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MalpracticeInsuranceDeductible1": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of risk retained by the entity before the insurance arrangement begins to provide coverage.", "label": "Malpractice Insurance, Deductible", "terseLabel": "Self insurance retention limit" } } }, "localname": "MalpracticeInsuranceDeductible1", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ManagementFeesRevenue": { "auth_ref": [ "r48" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Revenue, comprised of base and incentive revenue derived from the management of joint ventures, managing third-party properties, or another entity's operations.", "label": "Management Fees Revenue", "terseLabel": "Intercompany management fees" } } }, "localname": "ManagementFeesRevenue", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r39", "r244", "r261" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestChangeInRedemptionValue": { "auth_ref": [ "r161", "r162", "r163", "r170" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.", "label": "Noncontrolling Interest, Change in Redemption Value", "terseLabel": "Redemption adjustment on non-controlling interests" } } }, "localname": "MinorityInterestChangeInRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r169" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedLabel": "Distributions to and purchases of non-controlling interests" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r66", "r68" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r66", "r68" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r66", "r67", "r71" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r45", "r71", "r95", "r249", "r266" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.selectmedical.com/role/IncomePerCommonShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation", "verboseLabel": "Net income attributable to Select Medical Holdings Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r217", "r220" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Less: Net income attributable to non-controlling interests", "verboseLabel": "Less: Net income attributable to non-controlling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r50" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest.", "label": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net income attributable to non-controlling interests" } } }, "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r89" ], "calculation": { "http://www.selectmedical.com/role/IncomePerCommonShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net income available to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r82", "r83", "r84" ], "lang": { "en-US": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent and Recently Adopted Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonGuarantorSubsidiariesMember": { "auth_ref": [ "r155" ], "lang": { "en-US": { "role": { "documentation": "Entity owned or controlled by another entity which has not guaranteed the issue of securities by another subsidiary of the parent or has not guaranteed the issue of securities by the parent.", "label": "Non-Guarantor Subsidiaries [Member]", "terseLabel": "Non-Guarantor Subsidiaries" } } }, "localname": "NonGuarantorSubsidiariesMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r204" ], "lang": { "en-US": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Noncompete Agreements [Member]", "terseLabel": "Non-compete agreements" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r213" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingGainsLosses": { "auth_ref": [ "r54" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of gains or losses resulting from nonoperating activities (for example, interest and dividend revenue, property, plant and equipment impairment loss, and so forth).", "label": "Nonoperating Gains (Losses)", "terseLabel": "Non-operating gain", "verboseLabel": "Non-operating gain (loss)" } } }, "localname": "NonoperatingGainsLosses", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income and expense:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableOtherPayablesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A written promise to pay a note to a third party.", "label": "Notes Payable, Other Payables [Member]", "terseLabel": "Other" } } }, "localname": "NotesPayableOtherPayablesMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OffMarketFavorableLeaseMember": { "auth_ref": [ "r26" ], "lang": { "en-US": { "role": { "documentation": "Identifiable intangible asset established upon acquisition based on a favorable difference between the terms of an acquired lease and the current market terms for that lease.", "label": "Off-Market Favorable Lease [Member]", "terseLabel": "Favorable leasehold interests" } } }, "localname": "OffMarketFavorableLeaseMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income (loss) from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r223" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/BasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r7", "r8", "r9", "r32" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Accrued other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other non-current liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentCompanyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The registrant that controls, directly or indirectly, another entity (or entities). The usual condition for control is ownership of a majority (over 50%) of the outstanding voting stock. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders or by court decree.", "label": "Parent Company [Member]", "terseLabel": "Select (Parent Company Only)" } } }, "localname": "ParentCompanyMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Stockholders\u2019 Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfEquity": { "auth_ref": [ "r61" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common and preferred stock.", "label": "Payments for Repurchase of Equity", "negatedLabel": "Repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfEquity", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r63" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Revolving facility debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDistributionsToAffiliates": { "auth_ref": [ "r61" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Payments of Distributions to Affiliates", "negatedLabel": "Dividends paid to Holdings" } } }, "localname": "PaymentsOfDistributionsToAffiliates", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r61" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Payments of Ordinary Dividends, Noncontrolling Interest", "negatedLabel": "Distributions to non-controlling interests" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r56" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Business combinations, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r56" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedTerseLabel": "Investment in businesses" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r57" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedLabel": "Purchases of property and equipment", "verboseLabel": "Purchases of property and equipment, net" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidTaxes": { "auth_ref": [ "r3", "r5", "r117", "r118" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Taxes", "terseLabel": "Prepaid income taxes" } } }, "localname": "PrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProFormaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial information that is based on fully or partially assumed figures or facts. For example, but not limited to, pro forma disclosure of a change in accounting principle of what earnings would have been if the new principle had been applied. Excludes forecasts.", "label": "Pro Forma [Member]", "terseLabel": "Pro Forma" } } }, "localname": "ProFormaMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromContributionsFromParent": { "auth_ref": [ "r60" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from parent as a source of financing that is recorded as additional paid in capital.", "label": "Proceeds from Contributions from Parent", "terseLabel": "Equity investment by Holdings" } } }, "localname": "ProceedsFromContributionsFromParent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "auth_ref": [ "r59" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.", "label": "Proceeds from Issuance of Secured Debt", "terseLabel": "Proceeds from term loans", "verboseLabel": "Proceeds from term loans (financing costs)" } } }, "localname": "ProceedsFromIssuanceOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r59", "r76" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Borrowings on revolving facilities" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherShortTermDebt": { "auth_ref": [ "r59" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from short-term debt classified as other.", "label": "Proceeds from Other Short-term Debt", "terseLabel": "Borrowings of other debt" } } }, "localname": "ProceedsFromOtherShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsToMinorityShareholders": { "auth_ref": [ "r64" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.", "label": "Proceeds from (Payments to) Noncontrolling Interests", "terseLabel": "Proceeds from issuance of non-controlling interests" } } }, "localname": "ProceedsFromPaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r58", "r184" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductOrServiceAxis": { "auth_ref": [ "r112", "r176", "r177" ], "lang": { "en-US": { "role": { "documentation": "Information by products and services or groups of similar products and services.", "label": "Products and Services [Axis]", "terseLabel": "Products and Services [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductsAndServicesDomain": { "auth_ref": [ "r112" ], "lang": { "en-US": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Products and Services [Domain]", "terseLabel": "Products and Services [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfessionalMalpracticeLiabilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business insurance coverage for professionals, such as doctors, lawyers, insurance agents, accountants, real estate agents, veterinarians, and others. This liability coverage insures losses for claims arising from mistakes and errors or omissions in the course of professional activities.", "label": "Professional Malpractice Liability Insurance [Member]", "terseLabel": "Professional liability claims" } } }, "localname": "ProfessionalMalpracticeLiabilityMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r215", "r217", "r218", "r220", "r221" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r10", "r11", "r140", "r263" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r53", "r69", "r172", "r175" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.", "label": "Provision for Doubtful Accounts", "verboseLabel": "Provision for bad debts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by range, including, but not limited to, upper and lower bounds.", "label": "Range [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extent of variation, for example, but not limited to, upper and lower bounds.", "label": "Range [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r109", "r111" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "terseLabel": "Schedule of reconciliation of Adjusted EBITDA to income before income taxes" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r159", "r160", "r161", "r162" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "terseLabel": "Redeemable non-controlling interests" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r237" ], "lang": { "en-US": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r232", "r233", "r234", "r235", "r236" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": { "auth_ref": [], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt and payment of capital lease obligations.", "label": "Repayments of Debt and Capital Lease Obligations", "negatedTerseLabel": "Principal payments on other debt" } } }, "localname": "RepaymentsOfDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "auth_ref": [ "r62" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Repayments of Long-term Lines of Credit", "negatedLabel": "Payments on revolving facilities" } } }, "localname": "RepaymentsOfLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r62" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "Repayments of Secured Debt", "negatedTerseLabel": "Payments on term loans" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReportableLegalEntitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Legal entities of the consolidated entity reporting separate financial information in the entity's financial statements.", "label": "Reportable Legal Entities [Member]", "terseLabel": "Reportable legal entities" } } }, "localname": "ReportableLegalEntitiesMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestatementAdjustmentMember": { "auth_ref": [ "r85", "r86" ], "lang": { "en-US": { "role": { "documentation": "Effect of a correction of an error, other prior year adjustment, or application of a new accounting pronouncement on a financial statement line item or any per share amounts. The cumulative effect of the change on retained earnings or net assets in the statement of financial position would also be represented under this domain member.", "label": "Restatement Adjustment [Member]", "terseLabel": "Adoption Impact" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r19", "r169", "r260" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings (accumulated deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings (Accumulated Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r171", "r173", "r174", "r176" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "verboseLabel": "Total net operating revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r81", "r179" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue from Contracts with Customers" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/RevenueFromContractsWithCustomers" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r49" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net operating revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r85", "r86", "r87" ], "lang": { "en-US": { "role": { "documentation": "Represents the amount as previously reported before the correction of an error or other adjustment.", "label": "Scenario, Previously Reported [Member]", "terseLabel": "As Reported" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Any scenario, that is, the particular reporting scenario is left unspecified. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures.", "label": "Scenario, Unspecified [Domain]", "terseLabel": "Scenario, Unspecified [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails", "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r199", "r200" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails", "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCondensedBalanceSheetTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "Condensed Balance Sheet [Table Text Block]", "terseLabel": "Schedule of Condensed Consolidating Balance Sheet" } } }, "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCondensedCashFlowStatementTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.", "label": "Condensed Cash Flow Statement [Table Text Block]", "terseLabel": "Schedule of Condensed Consolidating Statement of Cash Flows" } } }, "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCondensedFinancialStatementsTable": { "auth_ref": [ "r0", "r79", "r212", "r252", "r255" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.", "label": "Condensed Financial Statements [Table]", "terseLabel": "Condensed Financial Statements [Table]" } } }, "localname": "ScheduleOfCondensedFinancialStatementsTable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCondensedIncomeStatementTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.", "label": "Condensed Income Statement [Table Text Block]", "terseLabel": "Schedule of Condensed Consolidating Statement of Operations" } } }, "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r35", "r75", "r165", "r166", "r167", "r168", "r227", "r228", "r231", "r254" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Company's long-term debt and notes payable" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r95" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of computation of basic and diluted earnings per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomePerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r187" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliations of the statutory federal income tax rate to the effective income tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [ "r129" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.", "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Schedule of finite-lived intangible assets acquired as part of business combination" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r125", "r126" ], "lang": { "en-US": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r125", "r126" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of carrying amount of goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r125" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "terseLabel": "Schedule of carrying value and amortization of identifiable intangible assets" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis": { "auth_ref": [ "r269", "r270", "r271", "r272" ], "lang": { "en-US": { "role": { "documentation": "Information by type of insurance coverage or layer of insurance that covers malpractice claims.", "label": "Insurance Type and Tier Identifier [Axis]", "terseLabel": "Insurance Type and Tier Identifier [Axis]" } } }, "localname": "ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r152" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]", "terseLabel": "Schedule of principal maturities of the Company's long-term debt and notes payable" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r82", "r83", "r84", "r98", "r99", "r101" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]", "terseLabel": "Schedule of effects on financial statement lines for adoption of new standard" } } }, "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r202" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of reconciliation of preliminary allocation of fair value to identifiable net assets and goodwill acquired to the consideration given for the acquired business" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r106", "r107", "r108", "r110", "r125" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r106", "r107", "r108", "r110", "r125" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of selected financial data for the Company's reportable segments" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r133" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of amortization expense for customer relationships, non-compete agreements, and trademarks" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails", "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment information" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationNarrativeDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableFairValueDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r69" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.", "label": "Share-based Compensation", "terseLabel": "Stock compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r81" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r105" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountOfGoodwillDetails", "http://www.selectmedical.com/role/RevenueFromContractsWithCustomersDetails", "http://www.selectmedical.com/role/SegmentInformationReconciliationOfAdjustedEbitdaToIncomeBeforeTaxesDetails", "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r38", "r164" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementScenarioAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by scenario to be reported. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails", "http://www.selectmedical.com/role/AcquisitionsProFormaResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": { "auth_ref": [ "r15", "r16", "r164", "r169" ], "lang": { "en-US": { "role": { "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited", "negatedTerseLabel": "Forfeitures of unvested restricted stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r164", "r169" ], "lang": { "en-US": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Issuance of restricted stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r15", "r16", "r164", "r169", "r182" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "terseLabel": "Exercise of stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": { "auth_ref": [ "r15", "r16", "r164", "r169" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures", "negatedTerseLabel": "Forfeitures of unvested restricted stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r15", "r16", "r164", "r169" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Issuance of restricted stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r38", "r164", "r169" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r15", "r16", "r164", "r169" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "negatedLabel": "Repurchase of common shares (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r15", "r16", "r164", "r169" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock Repurchased and Retired During Period, Value", "negatedLabel": "Repurchase of common shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r16", "r20", "r21", "r115" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r213", "r214", "r219" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders\u2019 Equity:", "verboseLabel": "Stockholders\u2019 Equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.", "label": "Stockholders' Equity, Other", "negatedLabel": "Other" } } }, "localname": "StockholdersEquityOther", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r238" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r238" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r239" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiariesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Entity owned or controlled by another entity.", "label": "Subsidiaries [Member]", "terseLabel": "Select Medical Corporation" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationNarrativeDetails", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationTables" ], "xbrltype": "domainItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Income taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "terseLabel": "Redemption adjustment on non-controlling interests" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityNetIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of net income or loss attributable to temporary equity interest.", "label": "Temporary Equity, Net Income", "terseLabel": "Net income attributable to non-controlling interests" } } }, "localname": "TemporaryEquityNetIncome", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityOtherChanges": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in temporary equity from changes classified as other.", "label": "Temporary Equity, Other Changes", "terseLabel": "Other" } } }, "localname": "TemporaryEquityOtherChanges", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfChangesInEquityAndIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r203" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AcquisitionsUSHealthworksAcquisitionDetails", "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueAndAmortizationOfIdentifiableIntangibleAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeAndTierIdentifierDomain": { "auth_ref": [ "r269" ], "lang": { "en-US": { "role": { "documentation": "Name of the type of insurance coverage or layer of insurance that covers malpractice claims.", "label": "Type and Tier Identifier [Domain]", "terseLabel": "Type and Tier Identifier [Domain]" } } }, "localname": "TypeAndTierIdentifierDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CommitmentsAndContingenciesLitigationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.", "label": "Type of Adoption [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [ "r27" ], "calculation": { "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "negatedLabel": "Unamortized Issuance Costs" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableComponentsOfLongTermDebtAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "auth_ref": [ "r93" ], "calculation": { "http://www.selectmedical.com/role/IncomePerCommonShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic", "terseLabel": "Less: Earnings allocated to unvested restricted stockholders" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r102", "r103", "r104" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableSelectCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToConcentraCreditFacilitiesDetails", "http://www.selectmedical.com/role/SubsequentEventsAmendmentToSelectCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]", "terseLabel": "Effect of dilutive securities:" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r90", "r94" ], "calculation": { "http://www.selectmedical.com/role/IncomePerCommonShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Weighted average shares\u2014diluted (in shares)", "verboseLabel": "Diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r88", "r94" ], "calculation": { "http://www.selectmedical.com/role/IncomePerCommonShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares\u2014basic (in shares)", "verboseLabel": "Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/IncomePerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WriteOffOfDeferredDebtIssuanceCost": { "auth_ref": [ "r55" ], "calculation": { "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails": { "order": 1.0, "parentTag": "us-gaap_GainsLossesOnExtinguishmentOfDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.", "label": "Write off of Deferred Debt Issuance Cost", "terseLabel": "Loss on extinguishment of debt" } } }, "localname": "WriteOffOfDeferredDebtIssuanceCost", "nsuri": "http://fasb.org/us-gaap/2017-01-31", "presentation": [ "http://www.selectmedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.selectmedical.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfCashFlowsDetails", "http://www.selectmedical.com/role/LongTermDebtAndNotesPayableLossOnEarlyRetirementOfDebtDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-04(c)(Schedule I))", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=27047687&loc=d3e5864-122674" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.10-01(a))", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.10-01.(b)(6))", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=84177426&loc=d3e6061-108592" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=84177426&loc=d3e6132-108592" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=84177426&loc=d3e6143-108592" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=66022249&loc=d3e33749-111570" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5865-108316" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r138": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14615-108349" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14394-108349" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14453-108349" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14472-108349" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14557-108349" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=82913245&loc=d3e12021-110248" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=82913245&loc=d3e12053-110248" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-10(d)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=27011887&loc=d3e168853-122756" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-10(d)(4))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=27011887&loc=d3e168853-122756" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "16(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=84159872&loc=d3e21506-112644" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=84159872&loc=d3e21521-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=84159872&loc=d3e21538-112644" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "32", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82859839&loc=SL82860478-203043" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130534-203044" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82913847&loc=SL49130539-203045" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82913847&loc=SL49130543-203045" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82913847&loc=SL49130543-203045" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82913847&loc=SL49130545-203045" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=96862333&loc=SL49130690-203046-203046" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82856876&loc=SL49131195-203048" }, "r179": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=96867065&loc=SL79508275-113901" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e31931-109318" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=84229725&loc=d3e961-128460" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=84229725&loc=d3e1043-128460" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)-(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r211": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=96868048&loc=d3e5283-111683" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=96868048&loc=SL4568447-111683" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=96868048&loc=SL4568740-111683" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=96868048&loc=SL4569616-111683" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=84161450&loc=d3e5614-111684" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=84161450&loc=SL4573702-111684" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=84161450&loc=SL4573702-111684" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=84234705&loc=SL4590271-111686" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-04(b))", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=27015204&loc=d3e355119-122828" }, "r223": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=77997519&loc=d3e13433-108611" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=77997519&loc=d3e13476-108611" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930785&loc=d3e28555-108399" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930785&loc=d3e28567-108399" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r239": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-06)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6882215&loc=d3e537971-122884" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.7-05(c)(Schedule II))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879921&loc=d3e569147-122900" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.15)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "720", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=49178521&loc=d3e9100-115647" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "720", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=49178521&loc=d3e9113-115647" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "720", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=49178521&loc=d3e9127-115647" }, "r273": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12b", "Subsection": "1" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(d))", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6787-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(d))", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.5)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7,9)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=SL94080555-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3536-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3574-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6911-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98514028&loc=d3e3044-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r81": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=64853466&loc=d3e22499-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=64853466&loc=d3e22580-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=64853466&loc=d3e22583-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=64853466&loc=d3e22644-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=64853466&loc=d3e22658-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=64853466&loc=d3e22663-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=96947427&loc=d3e1448-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=96947427&loc=d3e1377-109256" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e7018-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=96947427&loc=d3e1505-109256" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=96947427&loc=d3e1252-109256" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=96947427&loc=d3e1500-109256" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=96947427&loc=SL5780133-109256" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=96948231&loc=d3e4984-109258" }, "r97": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305" } }, "version": "2.0" }